Protein design and engineering market to reach $15.71B by 2030

The protein design and engineering market is projected to nearly double from 2025 to 2030, driven by AI drug discovery, precision medicine, synthetic biology, and rising biologics demand. North America leads today, while Asia-Pacific is expected to grow fastest.

Why it matters: - Protein design and engineering is becoming a core enabling market for biologics, therapeutics, enzymes and biomaterials. - The sector’s growth tracks with demand for more precise, stable and effective treatments. - Faster protein modeling and optimization could shorten drug development timelines and expand what researchers can build.

What happened: - The Business Research Company released a 2026 report on the global protein design and engineering market. - The report estimates market size at $7.62 billion in 2025 and $8.79 billion in 2026. - The report forecasts the market will reach $15.71 billion by 2030. - The report projects a 15.4% CAGR from 2025 to 2026 and a 15.6% CAGR from 2026 to 2030. - The report was published July 21, 2026. - A free sample is available here. - The full report is available here.

The details: - Protein design and engineering covers creating new proteins or modifying existing ones to produce specific structural or functional traits. - The field combines biology, chemistry and computational modeling to predict protein folding and behavior. - The report links past growth to molecular biology advances, higher pharmaceutical R&D spending, recombinant DNA adoption, structural biology tools, and demand for advanced biologics and vaccines. - The report points to AI-driven drug discovery, personalized therapeutics, synthetic biology, precision medicine funding and high-performance computing as major growth drivers through 2030. - The report highlights AI-based protein structure prediction, computational enzyme design, de novo protein engineering, synthetic biology for customized biomaterials and high-throughput screening as major trends. - The report says biologics are a major growth driver because protein design can improve stability, efficacy and target specificity. - The World Health Organization reported in February 2025 that the 2023 WHO Essential Medicines List includes 81 biologic therapies, more than 15% of all listed medicines. - North America held the largest share of the market in 2025. - Asia-Pacific is forecast to be the fastest-growing region. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The forecast suggests protein engineering is moving from a specialized research niche toward a broader commercial platform for drug discovery and advanced materials. - AI and high-performance computing are becoming central because they reduce the trial-and-error burden in protein design. - The biologics data points to continued demand for engineered proteins in medicine, not just industrial applications.

What's next: - The market is expected to keep expanding as AI tools, synthetic biology methods and precision medicine budgets scale up. - Demand should rise for protein structure prediction platforms, enzyme optimization tools and screening systems that can improve development speed. - Regional competition is likely to intensify as Asia-Pacific closes the gap on North America in growth rate.

The bottom line: - Protein design and engineering is set for sustained double-digit growth, with biologics and AI-driven discovery driving the next phase of expansion.